###begin article-title 0
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Contributions of MYOC and CYP1B1 mutations to JOAG
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
To investigate the role of MYOC and CYP1B1 in Iranian juvenile open angle glaucoma (JOAG) patients.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 442 446 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 451 457 451 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Twenty-three JOAG probands, their available affected and unaffected family members, and 100 ethnically matched control individuals without history of ocular disease were recruited. Clinical examinations of the probands included slit lamp biomicroscopy, intraocular pressure (IOP) measurement, gonioscopic evaluation, fundus examination, and perimetry measurement. Familial cases were classified according to the mode of inheritance. Exons of MYOC and CYP1B1 were sequenced, and novel variations assessed in the control individuals. Potential disease-associated variations were tested for segregation with disease status in available family members.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 237 243 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 508 514 508 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 176 184 <span type="species:ncbi:9606">patients</span>
###xml 490 498 <span type="species:ncbi:9606">patients</span>
###xml 536 544 <span type="species:ncbi:9606">patients</span>
The mode of inheritance of the disease in the families of four probands (17.4%) appeared to be autosomal dominant and in at least eight (34.8%) to be autosomal recessive. Four patients carried MYOC mutations, and an equal number carried CYP1B1 mutations. The MYOC mutations were heterozygous; two of them (p.C8X and p.L334P) are novel, and one codes for the shortest truncated protein so far reported. Autosomal recessive inheritance was consistent with inheritance observed in families of patients carrying CYP1B1 mutations. All these patients carried homozygous mutations.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
###xml 168 175 <span type="species:ncbi:9606">patient</span>
###xml 233 241 <span type="species:ncbi:9606">patients</span>
MYOC and CYP1B1 contributed equally to the disease status of the Iranian JOAG patients studied. The contribution of the two genes appeared to be independent in that no patient carried mutations in both genes. The fraction of Iranian patients carrying MYOC mutations was comparable to previously reported populations.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 783 784 783 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 941 942 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1110 1111 1110 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1112 1113 1112 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 1266 1267 1266 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 1440 1441 1440 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 523 529 <span type="species:ncbi:9606">people</span>
Glaucoma is a heterogeneous group of optic neuropathies, which manifest by optic nerve head cupping or degeneration of the optic nerve, resulting in a specific pattern of visual field loss [1-3]. Increased intraocular pressure (IOP) is often associated with the condition. If not treated by medical or surgical therapy in time, glaucoma leads to irreversible visual field loss and, ultimately, blindness. Therefore, diagnosis at an early stage of the disease is very important. The disease affects approximately 65 million people worldwide and is considered the second leading cause of blindness [4]. Glaucoma in some families demonstrates Mendelian inheritance. It is sub-grouped into three major classes on the basis of etiology, anatomy of the anterior chamber, and age of onset [1]. Primary open-angle glaucoma (POAG; OMIM ) accounts for 70% of glaucoma cases in Caucasian populations and usually affects individuals past the age of 40 [5]. In this form of glaucoma, the anterior chamber angle and the trabecular meshwork appear normal. It is associated with variable severity and phenotypic expressivity [6,7]. POAG is sometimes divided into the two sub-classes of adult-onset and juvenile-onset, the latter appearing between early childhood and the age of 40 [7]. The more rare juvenile form (JOAG) has been reported to usually exhibit autosomal dominant inheritance. Clinical features of the juvenile form are generally more severe [6].
###end p 11
###begin p 12
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 384 385 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 498 502 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 755 757 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 776 780 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 929 930 929 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 931 932 931 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 933 935 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 936 938 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 822 830 <span type="species:ncbi:9606">patients</span>
Although many loci have been reported for POAG, (GLC1A to GLC1N; ), genes for only three have been identified [2]. The three genes code for myocilin (MYOC; GLC1A; OMIM ), optineurin (OPTN; GLC1E; OMIM ), and WD repeat containing protein 36 (WDR36; GLC1G; OMIM ) [7-9]. The functions of these genes in the eye are not known. Myocilin is a bipartite protein, containing a myosin-like NH2-terminal domain and an olfactomedin homology COOH-terminal domain [10]. Most of disease-associated mutations in MYOC affect the olfactomedin-like domain. Haploinsufficiency does not appear to be the primary disease mechanism of MYOC mutations [11]. Several studies have indicated that mutant forms are associated with a gain of function or negative dominant effect [10,12-15]. Mutations in MYOC have been found in sporadic cases and in patients inheriting the disease in an autosomal dominant fashion, most often in those with juvenile onset [6,7,16,17]. There is evidence that interactions between different genes may cause glaucoma in some individuals [18-22].
###end p 12
###begin p 13
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 219 225 219 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
CYP1B1 (OMIM ), encoding cytochrome P4501B1, is a gene commonly associated with primary congenital glaucoma (PCG; OMIM ); however, mutations in CYP1B1 have been reported in JOAG patients [23-27]. Some patients carrying CYP1B1 mutations also carried MYOC mutations and the etiology of disease in these was considered digenic. The pathway by which CYP1B1 causes glaucoma is not understood [26,27]. PCG is characterized by an anatomic defect of the trabecular meshwork (trabeculodysgenesis) and an age of onset in the neonatal or infantile period.
###end p 13
###begin p 14
###xml 170 176 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 218 224 218 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 275 283 <span type="species:ncbi:9606">patients</span>
###xml 359 367 <span type="species:ncbi:9606">patients</span>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
The genetic basis of PCG among Iranian patients has recently been studied, and it was found that nearly 70% of Iranian PCG patients carry disease-associated mutations in CYP1B1 [28]. In other populations, mutations in CYP1B1 account for the disease status of 20%-100% of PCG patients [29]. A heterogeneous range of mutations were identified among the Iranian patients, many of which were novel. Here, we assess the association of MYOC and CYP1B1 in a cohort of 23 Iranians affected with JOAG. Phenotypic features of patients carrying mutations in these genes are presented.
###end p 14
###begin p 15
###xml 25 26 25 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 295 296 295 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 310 311 310 311 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 478 479 478 479 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Iranian JOAG pedigrees. (A) JG 102: Inheritance in this pedigree does not appear to be conclusively autosomal dominant because individuals of generation I are unaffected. Autosomal recessive inheritance seemed possible because of consanguinity and extensive inbreeding in village of residence. (B) JG 103 and (C) JG 111: Autosomal recessive inheritance is suggested in these two pedigrees because of multiple affected siblings born to unaffected parents who are first cousins. (D) JG 118: Autosomal dominant inheritance is suggested in this pedigree because affected individuals are observed in three consecutive generations. The affected individuals of the last two generations each had only one affected parent.
###end p 15
###begin title 16
Methods
###end title 16
###begin p 17
###xml 202 214 <span type="species:ncbi:9606">participants</span>
###xml 353 361 <span type="species:ncbi:9606">patients</span>
###xml 580 588 <span type="species:ncbi:9606">patients</span>
###xml 634 642 <span type="species:ncbi:9606">patients</span>
###xml 1325 1333 <span type="species:ncbi:9606">patients</span>
###xml 1402 1410 <span type="species:ncbi:9606">Patients</span>
This research was performed in accordance with the Declaration of Helsinki and with the approval of the Ethics Board of the International Institute of Genetic Engineering and Biotechnology in Iran. The participants or authorized family members all consented to participate after being informed of the nature of the research. Twenty-three unrelated JOAG patients were recruited from the ophthalmic division of the Labafi-Nejhad Hospital (associated with Shahid Beheshti University of Medical Sciences and Health Services) in Tehran. The hospital is a national reference center and patients from throughout Iran are referred to it. All patients were diagnosed by one of the authors (S.Y.) who is a glaucoma specialist. Slit lamp biomicroscopy, IOP measurement, gonioscopic evaluation of the angle, fundus examination, and measurement of perimetry were performed whenever possible. IOP measurements were obtained using Goldmann tonometry. Criteria for diagnosis were the presence of at least two of these criteria: an IOP greater than 21 mmHg in at least one eye or intereye IOP asymmetry exceeding 8 mmHg; characteristic glaucomatous optic nerve head or retinal nerve fiber layer (RNFL) changes (e.g., vertical cupping, neural rim thinning or loss, RNFL dropout); and visual field defects not attributable to other causes. All patients presented with an open anterior chamber angle in the affected eyes. Patients with other ocular or systemic anomalies were excluded. Classification of juvenile onset POAG was based on the age of diagnosis, ranging between the age of 10 and 40 years. One-hundred ethnically matched, unrelated control individuals were also recruited from those older than 60 years of age and without self-reported familial history of ocular diseases.
###end p 17
###begin title 18
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Mode of JOAG inheritance in families of patients.
###end title 18
###begin p 19
Sporadic cases are indicated in the left-most column. The next three columns separate the familial cases according to criteria by which they were classified as familial. The three right-most columns indicate mode of inheritance in each of the familial cases.
###end p 19
###begin p 20
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1006 1010 1006 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1262 1266 1262 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
The three exons of MYOC were amplified by polymerase chain reaction (PCR; primer sequences available upon request). All PCR products were sequenced in both forward and reverse directions with the same primers used in the PCRs, using the ABI big dye chemistry and an ABI Prism 3700 instrument (Applied Biosystems, Foster City, CA). Sequences were analyzed by comparing them to MYOC reference sequences (, , and ) using the Sequencher software (Gene Codes Corp., Ann Arbor, MI). To determine segregation of found variations with disease status in families, appropriate restriction enzyme digestion reactions were set up and restriction fragment length polymorphism (RFLP) was performed. Similarly, the presence of novel variations in control individuals was assessed by RFLP. Predicted effects of variant sequences on splicing were determined by comparison with known canonical splice site motifs at the splice site prediction by neural network . To assess the extent of conservation of a novel variation in MYOC thought to be associated with disease, the amino acid sequences of 12 myocilin proteins from as many species were obtained from  and aligned using the  software (European Bioinformatics Institute, Hinxton, UK). Core haplotypes defined by three common MYOC intragenic polymorphisms were assessed in the probands using .
###end p 20
###begin p 21
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 247 255 <span type="species:ncbi:9606">patients</span>
For mutation analysis of CYP1B1, coding exons 2 and 3 of CYP1B1 were sequenced and the sequences were analyzed as already reported [28]. Exon 1 of CYP1B1 was not analyzed because no disease-associated variations have been found among the many PCG patients screened from various populations [28,29].
###end p 21
###begin title 22
Results
###end title 22
###begin p 23
###xml 108 115 108 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
The clinical features of the sporadic JOAG patients and the probands of the familial cases are presented in Table 2. Average age of onset of the patients was 21.3 years old.
###end p 23
###begin title 24
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Phenotypic features of Iranian JOAG patients.
###end title 24
###begin p 25
###xml 461 465 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 648 652 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 739 745 739 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 234 242 <span type="species:ncbi:9606">patients</span>
###xml 631 639 <span type="species:ncbi:9606">patients</span>
###xml 722 730 <span type="species:ncbi:9606">patients</span>
###xml 840 848 <span type="species:ncbi:9606">patients</span>
###xml 890 898 <span type="species:ncbi:9606">patients</span>
Unknown clinical features are left blank. For familial cases, features of the proband of the families are presented. The meaning of each symbol and abbreviation is given in the following: F/S indicated the familial/sporadic status of patients: F, familial; S, sporadic; AD: autosomal dominant; AR: autosoamal recessive; ?: unknown mode of inheritance; R: right eye; L: left eye; Age of onset range is the range of age of onset in other affected family members; MYOC haplotypes are defined by SNPs at positions c.-83, c.227, and IVS2+35 in the same order. H1: -GGG-, H2: -GGA-, H3: -AAA-, H4: -AAG-; The sharp (hash mark) indicates patients in whom MYOC disease-associated variations were found; the double sharp indicates patients in whom CYP1B1 disease-associated variations were found; the asterisk indicates that the haplotypes of these patients were unambiguous. Those of the remaining patients were predicted.
###end p 25
###begin p 26
###xml 843 849 843 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 854 858 854 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1001 1010 1001 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 1169 1176 1169 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1210 1218 1210 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 88 96 <span type="species:ncbi:9606">Patients</span>
###xml 437 442 <span type="species:ncbi:9606">child</span>
The patients were recruited consecutively without regard to familial status of disease. Patients were designated sporadic if they reported no consanguinity between parents and no other incidence of disease among relatives. If the previous criteria did not apply, they were designated familial. The mode of inheritance before mutation analysis in some familial cases was not straightforward and these were indicated as unknown. Parent to child inheritance was not necessarily an indication of autosomal dominant inheritance because of extensive inbreeding in some pedigrees, and reported non-consanguinity may have been misleading as all individuals within a pedigree sometimes belonged to small isolated villages where consanguineous marriages were common. Classification was further hampered because of possible incomplete penetrance of both CYP1B1 and MYOC mutations [24,30-32]. An example of a pedigree (JG 102) in which the mode of inheritance was initially difficult to establish is presented in Figure 1A. For families where the mode of JOAG inheritance was clear, it was designated as autosomal recessive or autosomal dominant. The designations are presented in Table 1, and some pedigrees are shown in Figure 1.
###end p 26
###begin p 27
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 89 96 89 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 568 572 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 602 609 602 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
###xml 439 446 <span type="species:ncbi:9606">patient</span>
###xml 592 600 <span type="species:ncbi:9606">patients</span>
###xml 1018 1026 <span type="species:ncbi:9606">patients</span>
Seven sequence variations were identified in the MYOC gene of the Iranian JOAG patients (Table 3). Four of the variations, c.-83G>A, c.227G>A, IVS2+35G>A, and c.975G>A are single nucleotide polymorphisms (SNPs) previously reported not to be associated with disease [11,16,33,34]. The first three SNPs were common among our cohort of patients and were found in both the heterozygous and homozygous states. C.975G>A was observed in only one patient in the heterozygous state. Core intragenic SNP haplotypes defined by the three common variants were assessed for the two MYOC alleles of all the patients (Table 2). Seventeen of the probands were homozygous at all or heterozygous at most at one of these variant positions, and their haplotypes could therefore be defined unambiguously Four haplotypes, -GGG- (H1), -GGA- (H2),-AAA- (H3), and -AAG- (H4), that are defined by nucleotides at positions c.-83, c.227, and IVS2+35 were observed. H1 (47.7%) and H2 (36.4%) were by far the most common haplotypes in our cohort of patients.
###end p 27
###begin title 28
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
MYOC variations in Iranian JOAG patients.
###end title 28
###begin p 29
The asterisk shows that the reference sequences used were , , and, . Variations thought to cause JOAG are shown in bold. The meaning of each symbol is given in the following: the sharp (hash mark) indicates that the "A" of the initiation codon was designated +1; the double sharp indicates a novel mutation.
###end p 29
###begin p 30
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 61 69 61 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 983 990 983 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 1218 1227 1218 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 1683 1685 1683 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 1686 1688 1686 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 556 564 <span type="species:ncbi:9606">patients</span>
###xml 962 967 <span type="species:ncbi:9606">human</span>
###xml 972 981 <span type="species:ncbi:7955">zebrafish</span>
###xml 1053 1060 <span type="species:ncbi:9606">patient</span>
###xml 1731 1738 <span type="species:ncbi:9606">patient</span>
C.24C>A and c.1001T>C are novel sequence variations in MYOC (Figure 2). C.24C>A, observed in the heterozygous state in two patients (JG 123 and JG 130), creates a stop codon early in the coding sequence after the seventh amino acid residue (C8X). It is thought to be associated with JOAG because it was found in two unrelated sporadic JOAG patients, shown to be absent by RFLP in the DNA of three available unaffected family members, and shown to be absent by RFLP in 100 control individuals (not shown). Identity by descent of the C8X mutation in the two patients could not be established as it was associated on haplotype H1 in one (JG 123) and on haplotype H1 or H2 in the other (JG 130). C.1001T>C, which results in L334P in the olfactomedin domain, is also thought to be associated with disease status. It results in an amino acid alteration at a position completely conserved in the myocilin protein of 12 species, including species as distally related as human and zebrafish (Table 4; bold, underlined amino acid). The variation was found in one patient (JG 102) in the heterozygous state on haplotype background H2. It was shown by RFLP to segregate with disease status among available members of this family (Figure 1A). Additionally, it was not observed by RFLP in the DNA of 100 ethnically matched control individuals (not shown). Age of diagnosis of the four affected family members was between 7 and 20 years old. The variation c.1109C>T resulting in P370L in the olfactomedin domain, was found in one sporadic case (JG 104) in the heterozygous state on haplotype H2. This variation has previously been reported as a disease-associated variation in several populations [34-36]. It is likely to be the cause of JOAG in patient JG 104. Unfortunately, other family members were not available for genetic analysis.
###end p 30
###begin p 31
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 734 741 734 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 897 903 897 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 915 924 915 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 989 995 989 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1252 1258 1252 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1507 1509 1507 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 1705 1711 1705 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1820 1824 1820 1824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1829 1835 1829 1835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
###xml 218 226 <span type="species:ncbi:9606">patients</span>
###xml 321 328 <span type="species:ncbi:9606">patient</span>
###xml 343 350 <span type="species:ncbi:9606">patient</span>
###xml 505 513 <span type="species:ncbi:9606">patients</span>
###xml 586 594 <span type="species:ncbi:9606">patients</span>
###xml 663 671 <span type="species:ncbi:9606">patients</span>
###xml 1371 1379 <span type="species:ncbi:9606">patients</span>
###xml 1447 1455 <span type="species:ncbi:9606">patients</span>
###xml 1806 1814 <span type="species:ncbi:9606">patients</span>
Four of the Iranian JOAG patients carried disease-associated mutations in the CYP1B1 gene. All four carried the mutations in the homozygous state. C.182G>A (g. 3987G>A), causing G61E, was observed in three of the JOAG patients (JG 100, JG 103, and JG 114), and c. 1103G>A (g. 7940G>A), causing R368H, was observed in one patient (JG 129). The patient carrying R368H was affected with PCG in one eye (onset at birth) and with JOAG in the other. G61E and R368H have previously been reported to cause PCG in patients of various ethnicities, and they are common mutations among Iranian PCG patients [28]. The mode of inheritance in the pedigrees of three of the JOAG patients (JG 103, JG 129, and JG 114) was clearly autosomal recessive (Table 1). Affected siblings from only one of the pedigrees (JG 103) were available for genetic analysis, and it was shown by RFLP that they all carried homozygous CYP1B1 mutations (Figure 1B). Unfortunately, unaffected siblings in the four pedigrees with CYP1B1 mutations were not available for genetic analysis. However, some of the 14 unaffected siblings are expected to be heterozygous on a statistical basis. Similarly, the parents of three of the probands, all of whom are expected to harbor at least one mutated CYP1B1 allele, were self-reported not to be affected with an ocular disorder. It has been reported that parents of PCG patients, many of whom carried the same G61E mutation found in three of our patients, are not at increased risk of developing glaucoma [30]. The father in the fourth pedigree (JG 100) was affected, but he was an offspring of a consanguineous marriage in a highly inbred pedigree, making it possible that he too was homozygous for the CYP1B1 mutation. There was no obvious difference between age at diagnosis and phenotypic features of patients with MYOC and CYP1B1 mutations.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 301 308 301 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 19 27 <span type="species:ncbi:9606">patients</span>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
Our cohort of JOAG patients had two notable features. One is that of the patients whose disease was classified as familial, four belonged to pedigrees in which the mode of inheritance of disease was autosomal dominant while eight belonged to pedigrees with an autosomal recessive mode of inheritance (Table 1). Although autosomal recessive inheritance of JOAG has been reported, the inheritance of the disease for familial cases is generally considered to be autosomal dominant [1,6,36,37]. JOAG is caused by more than one gene, and some of the genes may exert their effect in a recessive fashion. The role of these genes is less likely to be discerned in genetic studies on populations where consanguineous marriages are infrequent, and most of the studies on JOAG have been done on such populations [35]. The relatively high rate of inbreeding within the Iranian population is expected to allow mutations in these putative genes to show their phenotypic effects. It would be of interest to establish whether autosomal recessive inheritance of JOAG is common in other populations where consanguineous marriages are common such as the population of Saudi Arabia.
###end p 33
###begin p 34
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 25 27 25 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 236 237 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Novel mutations in MYOC. A: At the top, the sequence chromatogram is showing the heterozygous mutation, c.24C>A, which causes the codon change UGC to UGA, resulting in C8X; at the bottom, the chromatograph shows the wild type sequence. B: The top sequence chromatogram shows the heterozygous mutation, c.1001T>C, which is causing codon change CUU to CCU, resulting in L334P; the bottom chromatograph illustrates the wild type sequence.
###end p 34
###begin p 35
###xml 265 272 265 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
Another interesting feature of our cohort is that among the 17 families in which more than one individual was affected, one member in five of the families (29.4%) was affected from the time of birth and could be classified as a case of primary congenital glaucoma (Table 2). The preponderance of this situation in multi-case families supports the proposal made by other investigators that the disturbance of common biochemical pathways may be involved in the etiology of PCG and JOAG [20,24,38]. The observations of PCG (onset at birth) in one eye and JOAG (onset at age of 12) in the other eye of two probands (JG 129 and JG 131) further support this conjecture.
###end p 35
###begin p 36
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 397 404 397 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 853 857 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 954 956 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 1105 1107 1105 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 1969 1973 1969 1973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1985 1987 1985 1987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1988 1990 1988 1990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 1991 1993 1991 1993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 2204 2206 2204 2206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 2207 2209 2207 2209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 2210 2212 2210 2212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 266 274 <span type="species:ncbi:9606">patients</span>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
###xml 704 712 <span type="species:ncbi:9606">patients</span>
A mutation in MYOC was assessed to be the cause of JOAG in 4 of the 23 probands (17.4%) screened. This figure falls within the range reported for other populations [6,16,17]. C.24C>A that causes C8X was a novel disease-associated variation observed in two unrelated patients. The phenotypic features of the two patients, including age at diagnosis, cup to disc ratio, and IOP, were quite similar (Table 2). The protein product of the mutated allele is expected to be the shortest truncated MYOC reported to date. In addition to causing early protein truncation during protein synthesis, the early nonsense codon may also result in reduced levels of mRNA [39]. Previously, mutation Arg46X was reported in patients from Korea, Japan, and China [17,33,36], all countries in the Far East. After initial association of Arg46X and several other variations in MYOC with glaucoma, the causative nucleotide changes were also identified in control individuals [33,40-42]. The absence of a tight association between the variations and disease phenotype is a reflection of the complexity of the etiology of glaucoma [35]. With regards to C8X, the causative mutation was absent in the DNA of three unaffected siblings (age 25-28 years old) and 100 control individuals. On the other hand, at least one parent of each of the probands is expected to have harbored the variation. Both parents of both probands were reported by the probands not to have any form of ocular disorder, suggesting incomplete penetrance. Unfortunately, the parents were not available for genetic analysis. C8X may accompany a normal phenotype within specific genetic and/or environmental backgrounds, and an assessment of its penetrance must await studies in larger cohorts of affected and normal controls. If indeed C8X can cause JOAG as it appears to do in the probands of JG 123 and JG 130, this raises questions with regards to a gain of function or negative dominant effect model of disease causation by MYOC mutations [10,12,13]. Either the mRNA or the very short truncated protein product of the mutated allele can exert the same effect, or other models such as haploinsufficiency must be considered for at least some of the variations [12,13,43].
###end p 36
###begin p 37
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r47">47</xref>
###xml 845 849 845 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 1034 1041 1034 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 205 213 <span type="species:ncbi:9606">patients</span>
###xml 708 716 <span type="species:ncbi:9606">patients</span>
###xml 906 911 <span type="species:ncbi:9606">human</span>
In addition to C8X, L334P was a novel disease-associated variation found among the Iranian pedigrees. Given that approximately 70 glaucoma-associated variations have been identified in MYOC among the many patients screened in the 10 years since the discovery of the gene, finding two novel mutations among only 23 probands is notable. This finding testifies to the high heterogeneity of the Iranian population and the potential value of this population for genetic studies [28,43,44]. With respect to MYOC, no single mutation has yet been observed in Caucasian, African, and Asian populations, and many mutations have been found in only specific regions [35,45-47]. As C8X was found in two unrelated Iranian patients and not found in other countries, it may have originated in Iran and so far have spread only to individuals within this region. MYOC mutations are generally considered relatively recent in human history [35]. C8X occurred on intragenic haplotype H1 and possibly H2, and L334P occurred on intragenic haplotype H2 (see Table 2). In case these variations are found in the future in other populations in association with different haplotypes, the observation will be an indication of a recurrence of mutation.
###end p 37
###begin title 38
Alignment of L334P in myocilin proteins.
###end title 38
###begin p 39
Sequence ID numbers are from the  and .
###end p 39
###begin p 40
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r48">48</xref>
###xml 81 86 <span type="species:ncbi:9606">human</span>
P370L is one of the few MYOC mutations likely to have occurred more than once in human history [48]. The mutation in the Iranian proband is associated with haplotype H2, but available information does not allow us to ascertain whether it shares ancestry with previously reported P370L alleles or represents an independent mutation event.
###end p 40
###begin p 41
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 324 330 324 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 475 479 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r49">49</xref>
###xml 567 573 567 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 606 610 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 801 807 801 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 849 855 849 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 902 906 902 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1008 1012 1008 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1114 1120 1114 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1194 1200 1194 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1316 1318 1316 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 1379 1383 1379 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1388 1392 1388 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1420 1426 1420 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1594 1600 1594 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1643 1645 1643 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 1653 1659 1653 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1795 1797 1795 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 1798 1800 1798 1800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
###xml 339 347 <span type="species:ncbi:9606">Patients</span>
###xml 713 721 <span type="species:ncbi:9606">patients</span>
###xml 947 955 <span type="species:ncbi:9606">patients</span>
###xml 1083 1091 <span type="species:ncbi:9606">patients</span>
###xml 1173 1181 <span type="species:ncbi:9606">patients</span>
###xml 1235 1243 <span type="species:ncbi:9606">patients</span>
###xml 1278 1286 <span type="species:ncbi:9606">patients</span>
###xml 1331 1338 <span type="species:ncbi:9606">patient</span>
###xml 1511 1519 <span type="species:ncbi:9606">patients</span>
###xml 1526 1533 <span type="species:ncbi:9606">persons</span>
###xml 1718 1726 <span type="species:ncbi:9606">patients</span>
Homozygous mutations in CYP1B1 were assessed to be the cause of JOAG in 4 of the 23 probands (17.4%) screened, the same number as those whose disease was caused by MYOC. Mutations in MYOC were not observed in any of these four patients, and none of the individuals in our cohort were observed to carry only a single mutated CYP1B1 allele. Patients affected with primary congenital or open angle glaucoma carrying double heterozygous mutations, one in CYP1B1 and the other in MYOC, have previously been reported in three studies [20,24,49]. The authors suggested that CYP1B1 may act as a modifier locus for MYOC in promoting open angle glaucoma. In another study, among a large cohort of 236 French Caucasian POAG patients (with the median age of 48 years at diagnosis), 12 individuals (5.1%) carrying CYP1B1 mutations were identified [21]. Only one CYP1B1 mutated allele was found in 10 of them, and a MYOC mutation was not found in any of the 12 patients. It was suggested that a modifying locus other than MYOC or environmental factors may be involved in the disease status of the patients carrying heterozygous CYP1B1 mutations. Similarly, in a recent study on 200 POAG patients from India, CYP1B1 mutations were identified in nine patients (4.5%) and only one of these nine patients carried two mutated alleles [23]. This JOAG patient was reported not to harbor mutations in MYOC and OPTN, and it was suggested that CYP1B1 was the primary cause of his disease status. Finally, in a study on 82 Spanish POAG patients, nine persons (10.9%) were reported to carry one putative disease-causing CYP1B1 allele; none carried two mutated alleles [25]. Both CYP1B1 mutations observed in the homozygous state in the Iranian patients were among the heterozygous mutations observed in previous studies [23,25].
###end p 41
###begin p 42
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 245 251 245 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 286 292 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
###xml 352 360 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
Compared to these studies, the observation that CYP1B1 appears to be the cause of JOAG in a larger proportion of the patients (17.4%) may not be significant because of our small sample size. However, it may reflect a higher frequency of mutated CYP1B1 alleles in the Iranian gene pool; CYP1B1 has a role in a relatively large percentage of Iranian PCG patients (70% as compared to 50% for French and 40% for Indian patients) [28].
###end p 42
###begin p 43
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 245 251 245 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 331 337 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
With respect to JOAG being associated with one or two mutated CYP1B1 alleles, it appears to be more often associated with two alleles in the Iranian population. Of course, it is possible that in a larger cohort, some JOAG patients with only one CYP1B1 mutated allele would be found. It may be that individuals carrying one mutated CYP1B1 allele will be only mildly symptomatic and therefore less likely to be identified.
###end p 43
###begin p 44
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 264 268 264 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
In conclusion, our results suggest that MYOC and CYP1B1 are each important in the etiology of JOAG, at least among Iranians. Precluding possible effects of common SNPs in the two genes, each appears to be able to promote disease independently, and therefore, both MYOC and CYP1B1 should be considered potential primary causes of JOAG. It is thus recommended that both genes be screened for mutations in individuals at risk, particularly in relatives of glaucoma-affected individuals known to harbor mutations in these genes. Non-interventionist treatments are likely to be effective if applied at early stages of disease progression and could help prevent irreversible visual impairment.
###end p 44
###begin title 45
Acknowledgments
###end title 45
###begin p 46
This research was funded by grant number 250 of the National Institute of Genetic Engineering and Biotechnology
###end p 46
###begin title 47
References
###end title 47
###begin article-title 48
Recent advances in molecular genetics of glaucoma.
###end article-title 48
###begin article-title 49
Gene mapping for primary open angle glaucoma.
###end article-title 49
###begin article-title 50
Recent advances in molecular genetics of glaucomas.
###end article-title 50
###begin article-title 51
###xml 10 16 <span type="species:ncbi:9606">people</span>
Number of people with glaucoma worldwide.
###end article-title 51
###begin article-title 52
A genomewide scan identifies novel early-onset primary open-angle glaucoma loci on 9q22 and 20p12.
###end article-title 52
###begin article-title 53
Identification of a gene that causes primary open angle glaucoma.
###end article-title 53
###begin article-title 54
Adult-onset primary open angle glaucoma caused by mutations in optineurin.
###end article-title 54
###begin article-title 55
Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1
###end article-title 55
###begin article-title 56
Myocilin and glaucoma: facts and ideas.
###end article-title 56
###begin article-title 57
Myocilin glaucoma.
###end article-title 57
###begin article-title 58
Homozygotes carrying an autosomoal dominant TIGR mutation do not manifest glaucoma.
###end article-title 58
###begin article-title 59
###xml 83 88 <span type="species:ncbi:9606">human</span>
ohn SWM, Johnson RL. Targeted disruption of the myocilin gene (Myoc) suggests that human glaucoma -causing mutations are gain of function.
###end article-title 59
###begin article-title 60
###xml 58 63 <span type="species:ncbi:9606">human</span>
Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment.
###end article-title 60
###begin article-title 61
Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure.
###end article-title 61
###begin article-title 62
Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A).
###end article-title 62
###begin article-title 63
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.
###end article-title 63
###begin article-title 64
Apolipoprotein e-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene.
###end article-title 64
###begin article-title 65
Evidence for genetic heterogeneity within eight glaucoma families, with the glc1a gln368stop mutation being an important phenotypic modifier.
###end article-title 65
###begin article-title 66
Digenic inheritance of early-onset glaucoma: Cyp1b1, a potential modifier gene.
###end article-title 66
###begin article-title 67
###xml 27 35 <span type="species:ncbi:9606">patients</span>
CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma.
###end article-title 67
###begin article-title 68
Evidence for a novel glaucoma locus at chromosome 3p21-22.
###end article-title 68
###begin article-title 69
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Primary role of CYP1B1 in Indian juvenile-onset POAG patients.
###end article-title 69
###begin article-title 70
Gln48His is the prevalent myocilin mutation in primary open angle and primary congenital glaucoma phenotypes in India.
###end article-title 70
###begin article-title 71
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Escribano.Heterozygous CYP1B1 gene mutations in Spanish patients with primary open-angle glaucoma.
###end article-title 71
###begin article-title 72
Clinical importance of the cytochromes P450.
###end article-title 72
###begin article-title 73
Roles of cytochromes P450 in development.
###end article-title 73
###begin article-title 74
###xml 63 71 <span type="species:ncbi:9606">patients</span>
CYP1B1 mutation profile of Iranian primary congenital glaucoma patients and associated haplotypes.
###end article-title 74
###begin article-title 75
Geneticsa and biochemistry of primary congenital glaucoma.
###end article-title 75
###begin article-title 76
Multiple CYp1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and adominant modifier locus.
###end article-title 76
###begin article-title 77
Correlation between genotype and phenotype in primary open angle glaucoma of Brazilian families with mutations in exon 3 of the TIGR/MYOC gene.
###end article-title 77
###begin article-title 78
Genetic homogeneity for inherited congenital microcoria loci in an Asian Indian pedigree.
###end article-title 78
###begin article-title 79
TIGR/MYOC gene sequence alterations in individuals with and without primary open- angle glaucoma.
###end article-title 79
###begin article-title 80
Myocilin allele-specific glaucoma phenotype database.
###end article-title 80
###begin article-title 81
Genetic dissection of myocilin glaucoma.
###end article-title 81
###begin article-title 82
###xml 17 26 17 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIGR/MYOC</italic>
Mutations of the TIGR/MYOC Gene in Primary Open-Angle Glaucoma in Korea. 1999
###end article-title 82
###begin article-title 83
Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma.
###end article-title 83
###begin article-title 84
Analysis of MYOC gene mutation in a Chinese glaucoma family with primary open-angle glaucoma and primary congenital glaucoma.
###end article-title 84
###begin article-title 85
Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain.
###end article-title 85
###begin article-title 86
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Analysis of myocilin gene mutations in Japanese patients with normal tension glaucoma and primary open-angle glaucoma.
###end article-title 86
###begin article-title 87
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Allelic variants in the MYOC/TIGR gene in patients with primary open-angle, exfoliative glaucoma and unaffected controls.
###end article-title 87
###begin article-title 88
###xml 37 44 <span type="species:ncbi:9606">patient</span>
Molecular and clinical evaluation of patient hemizygous for TIGR/MYOC.
###end article-title 88
###begin article-title 89
A haplotype framework for cystic fibrosis mutations in Iran.
###end article-title 89
###begin article-title 90
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TACSTD2</italic>
###xml 72 80 <span type="species:ncbi:9606">Patients</span>
Four mutations (three novel, one founder) in TACSTD2 among Iranian GDLD Patients.
###end article-title 90
###begin article-title 91
Founder effect in GLC1A-linked familial open-angle glaucoma in Northern France.
###end article-title 91
###begin article-title 92
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC1A</italic>
A novel Mutation in the GLC1A Gene Causes Juvenile Open-angle Glaucoma in 4 Families From the Italian Region of Puglia.
###end article-title 92
###begin article-title 93
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Novel mutation in the MYOC gene in primary open angle glaucoma patients.
###end article-title 93
###begin article-title 94
Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma.
###end article-title 94
###begin article-title 95
Myocilin gene implicated in primary congenital glaucoma.
###end article-title 95

